deferiprone has been researched along with Glomerulonephritis in 1 studies
Deferiprone: A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA.
deferiprone : A member of the class of 4-pyridones that is pyridin-4(1H)-one substituted at positions 1 and 2 by methyl groups and at position 3 by a hydroxy group. A lipid-soluble iron-chelator used for treatment of thalassaemia.
Glomerulonephritis: Inflammation of the renal glomeruli (KIDNEY GLOMERULUS) that can be classified by the type of glomerular injuries including antibody deposition, complement activation, cellular proliferation, and glomerulosclerosis. These structural and functional abnormalities usually lead to HEMATURIA; PROTEINURIA; HYPERTENSION; and RENAL INSUFFICIENCY.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rajapurkar, MM | 1 |
| Hegde, U | 1 |
| Bhattacharya, A | 1 |
| Alam, MG | 1 |
| Shah, SV | 1 |
1 trial available for deferiprone and Glomerulonephritis
| Article | Year |
|---|---|
Effect of deferiprone, an oral iron chelator, in diabetic and non-diabetic glomerular disease.
Topics: Adolescent; Adult; Child; Child, Preschool; Deferiprone; Diabetic Nephropathies; Drug Therapy, Combi | 2013 |